-
1
المؤلفون: Rüschoff, Josef, Lolkema, Martijn, GIANNI, LUCA, Voest, Emile, de Vries, Elisabeth, Tabernero, Josep
المساهمون: Institut Català de la Salut, [de Vries EGE] Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. [Rüschoff J] Targos Molecular Pathology GmbH, Kassel, Germany. [Lolkema M] Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. [Tabernero J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVicUCC, IOB-Quiron, Barcelona, Spain. [Gianni L] Michelangelo Foundation, Milan, Italy. [Voest E] Netherlands Cancer Institute, Amsterdam, The Netherlands. Oncode Institute, Amsterdam, The Netherlands, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES], neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::adenocarcinoma::colangiocarcinoma [ENFERMEDADES], Anticossos monoclonals - Ús terapèutic, Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma::Cholangiocarcinoma [DISEASES], neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias de la vejiga [ENFERMEDADES], Pàncrees - Càncer - Tractament, Bufeta - Càncer - Tractament, Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal [CHEMICALS AND DRUGS], Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Urinary Bladder Neoplasms [DISEASES], neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales [COMPUESTOS QUÍMICOS Y DROGAS]
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3991::e22b1a97656ac57cc288154b29ebac6e
https://hdl.handle.net/11351/9964 -
2
المؤلفون: Begoña P. Valderrama, Aránzazu González-del-Alba, Rafael Morales-Barrera, Ignacio Peláez Fernández, Sergio Vázquez, Cristina Caballero Díaz, Montserrat Domènech, Ovidio Fernández Calvo, Alfonso Gómez de Liaño Lista, José Ángel Arranz Arija
المساهمون: Institut Català de la Salut, [Valderrama BP] Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain. [González-Del-Alba A] Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. [Morales-Barrera R] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Peláez Fernández I] Medical Oncology Department, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain. [Vázquez S] Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain. [Caballero Díaz C] Medical Oncology Department, Hospital General Universitario de Valencia, Centro de Investigación Biomédica de Red en Cáncer (CIBERONC), Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Cancer Research, Muscle-invasive, Carcinoma, Transitional Cell, neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias de la vejiga [ENFERMEDADES], Muscles, Bladder cancer, General Medicine, Cystectomy, Quimioteràpia combinada, Neoadjuvant Therapy, Therapeutics::Combined Modality Therapy::Neoadjuvant Therapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Oncology, Urinary Bladder Neoplasms, Urothelial, Antineoplastic Combined Chemotherapy Protocols, Bufeta - Càncer - Tractament, Humans, terapéutica::tratamiento combinado::tratamiento neoadyuvante [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Neoplasm Invasiveness, Cisplatin, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Urinary Bladder Neoplasms [DISEASES]
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c580ab10d93ca25debafe3ec7dde0c
https://link.springer.com/content/pdf/10.1007/s12094-022-02815-w.pdf -
3
المساهمون: Departament de Salut
المصدر: Scientia
مصطلحات موضوعية: neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::carcinoma de células transicionales [ENFERMEDADES], Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Carcinoma, Transitional Cell [DISEASES], Bufeta - Càncer - Tractament, Avaluació de resultats (Assistència mèdica), Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Other subheadings::Other subheadings::/drug therapy [Other subheadings]
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3991::5240791e6260ed79e746d7a838a74961
https://hdl.handle.net/11351/8218 -
4
المؤلفون: Enrique Grande, A. Loehr, Petros Grivas, Dale L. Nepert, Yohann Loriot, Sumati Gupta, Daleen Thomas, Nicholas J. Vogelzang, Min Yuen Teo, Nabil Adra, Alejo Rodriguez-Vida, Rachel L. Dusek, Simon Chowdhury, S. Srinivas, Yousef Zakharia, Andrew Simmons, Andrea Necchi, Ajjai Alva, Susan Feyerabend, Kenton Wride, Rafael Morales-Barrera, Debra H. Josephs
المساهمون: University of Washington [Seattle], Fred Hutchinson Cancer Research Center [Seattle] (FHCRC), Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Passeig Vall d'Hebron [Barcelona, Spain], Memorial Sloane Kettering Cancer Center [New York], University of Iowa [Iowa City], Studienpraxis Urologie [Nürtingen, Germany], Comprehensive Cancer Centers [Las Vegas, NV, USA], MD Anderson Cancer Center [Madrid, Spain], Indiana State University, Department of Internal Medicine and Computational Medicine and Bioinformatics [Ann Arbor, MI, USA], University of Michigan [Ann Arbor], University of Michigan System-University of Michigan System, Human Tumor Immunobiology Unit [Fondazione IRCCS Istituto Nazionale dei Tumori, Milan], Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan], IMIM-Hospital del Mar, Generalitat de Catalunya, Huntsman Cancer Institute [Salt Lake City], University of Utah, Guy's and St Thomas NHS Foundation Trust [London], Stanford University School of Medicine [CA, USA], Clovis Oncology, Inc. [Boulder, CO, USA], Malbec, Odile, Institut Català de la Salut, [Grivas P] Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA 98109, USA. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. Seattle Cancer Care Alliance, Seattle, WA 98109, USA. [Loriot Y] Department of Medicine, Gustave Roussy Cancer Campus, INSERM U981, Université Paris-Saclay, 94800 Villejuif, France. [Morales-Barrera R] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Teo MY] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. [Zakharia Y] Division of Hematology, Oncology, and Blood and Marrow Transplant, University of Iowa and Holden Comprehensive Cancer Center, Iowa City, IA 52242, USA. [Feyerabend S] Studienpraxis Urologie, 72622 Nürtingen, Germany, Vall d'Hebron Barcelona Hospital Campus, Grivas, P., Loriot, Y., Morales-Barrera, R., Teo, M. Y., Zakharia, Y., Feyerabend, S., Vogelzang, N. J., Grande, E., Adra, N., Alva, A., Necchi, A., Rodriguez-Vida, A., Gupta, S., Josephs, D. H., Srinivas, S., Wride, K., Thomas, D., Simmons, A., Loehr, A., Dusek, R. L., Nepert, D., Chowdhury, S.
المصدر: BMC Cancer
BMC Cancer, BioMed Central, 2021, 21 (1), pp.593. ⟨10.1186/s12885-021-08085-z⟩
BMC Cancer, 2021, 21 (1), pp.593. ⟨10.1186/s12885-021-08085-z⟩
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Scientiaمصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Indoles, DNA Repair, [SDV]Life Sciences [q-bio], Administration, Oral, Loss of Heterozygosity, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Clinical endpoint, Inhibidors enzimàtics - Ús terapèutic - Eficàcia, RC254-282, BRCA1 Protein, Bladder cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, 3. Good health, [SDV] Life Sciences [q-bio], 030220 oncology & carcinogenesis, Bufeta - Càncer - Tractament, Other subheadings::Other subheadings::/administration & dosage [Other subheadings], Female, Urothelial carcinoma, medicine.symptom, Research Article, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Anemia, Nausea, Urinary Bladder, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Poly(ADP-ribose) Polymerase Inhibitors, 03 medical and health sciences, Internal medicine, Genetics, medicine, Humans, Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Poly(ADP-ribose) Polymerase Inhibitors [CHEMICALS AND DRUGS], Adverse effect, Rucaparib, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Urinary Bladder Neoplasms [DISEASES], Response Evaluation Criteria in Solid Tumors, Aged, BRCA2 Protein, Genomic biomarkers, Carcinoma, Transitional Cell, Otros calificadores::Otros calificadores::/administración & dosificación [Otros calificadores], neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias de la vejiga [ENFERMEDADES], business.industry, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de poli(ADP-ribosa) polimerasas [COMPUESTOS QUÍMICOS Y DROGAS], medicine.disease, PARP inhibitor, 030104 developmental biology, Urinary Bladder Neoplasms, chemistry, business, Follow-Up Studies
وصف الملف: application/pdf
-
5
المساهمون: Gelabert Mas, Antonio, Ibarz Servio, Luis
مصطلحات موضوعية: Bufeta Càncer Quimioteràpia, Bufeta Càncer Immunoteràpia, Pacients Avaluació Satisfacció, Bufeta Càncer Tractament
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______272::d85803a7a03ef6ddd15f99e34586ba03
https://hdl.handle.net/2072/420462 -
6
المؤلفون: Valverde Vilamala, Ivanna, Universitat Autònoma de Barcelona. Departament de Cirurgia, Universitat Autònoma de Barcelona. Facultat de Medicina
المساهمون: Gelabert Mas, Antonio, Ibarz Servio, Luis
المصدر: Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)مصطلحات موضوعية: Bufeta Càncer Quimioteràpia, Bufeta Càncer Immunoteràpia, Pacients Avaluació Satisfacció, Bufeta Càncer Tractament
URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d85803a7a03ef6ddd15f99e34586ba03
http://hdl.handle.net/2072/420462 -
7
المؤلفون: Thomas Powles, Srikala S. Sridhar, Yohann Loriot, Joaquim Bellmunt, Xinmeng Jasmine Mu, Keith A. Ching, Jie Pu, Cora N. Sternberg, Daniel P. Petrylak, Rosa Tambaro, Louis M. Dourthe, Carlos Alvarez-Fernandez, Maureen Aarts, Alessandra di Pietro, Petros Grivas, Craig B. Davis
المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)
المصدر: Nature Medicine, 27(12), 2200-2211. Nature Publishing Group
مصطلحات موضوعية: CLINICAL BENEFIT, MULTICENTER, DNA-DAMAGE RESPONSE, General Medicine, Antibodies, Monoclonal, Humanized, OPEN-LABEL, CANCER, General Biochemistry, Genetics and Molecular Biology, Antineoplastic Agents, Immunological, Urinary Bladder Neoplasms, TUMOR, PD-1/PD-L1 BLOCKADE, Mutation, Marcadors bioquímics, Biomarkers, Tumor, REGULARIZATION, Humans, IMMUNOTHERAPY, Bufeta--Càncer--Tractament, PEMBROLIZUMAB, Càncer
وصف الملف: application/pdf
-
8
المؤلفون: Joaquin Bellmunt, Nicholas J. Vogelzang, Thomas Powles
المصدر: Cancer Treatment Reviews. 54:58-67
مصطلحات موضوعية: 0301 basic medicine, Durvalumab, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, Avelumab, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Humans, Medicine, Radiology, Nuclear Medicine and imaging, Molecular Targeted Therapy, PD-L1 inhibitor, Bufeta -- Càncer -- Tractament, Bladder cancer, business.industry, Antibodies, Monoclonal, General Medicine, Immunotherapy, medicine.disease, PD-1 inhibitor, Nivolumab, 030104 developmental biology, Urinary Bladder Neoplasms, Oncology, Radiology Nuclear Medicine and imaging, 030220 oncology & carcinogenesis, Immunology, Cancer research, business, medicine.drug
وصف الملف: application/pdf
-
9
المؤلفون: B. Pérez-Valderrama, Sergio Vázquez, José Muñoz-Langa, Nuria Lainez, A. González del Alba, G. de Velasco, Cristina Caballero, Rafael Morales-Barrera, Pablo Maroto, Laura Basterretxea
المساهمون: [González Del Alba A] Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Joaquin Rodrigo 2, 28222 Majadahonda, Madrid, Spain. [De Velasco G] Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain. [Lainez N] Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain. [Maroto P] Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Morales-Barrera R] Genitourinary, CNS and Sarcoma Tumors Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Muñoz-Langa J] Medical Oncology Department, Hospital Universitari I Politècnic la Fe, Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus, Hospital Universitari Vall d'Hebron
المصدر: CLINICAL & TRANSLATIONAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunyaمصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_treatment, Pembrolizumab, chemistry.chemical_compound, 0302 clinical medicine, Societies, Medical, Otros calificadores::/terapia [Otros calificadores], Clinical Trials as Topic, Muscle Neoplasms, Vinflunine, Bladder cancer, Neoplasms::Neoplastic Processes::Neoplasm Metastasis [DISEASES], Disease Management, Combination chemotherapy, General Medicine, Prognosis, Combined Modality Therapy, 030220 oncology & carcinogenesis, Practice Guidelines as Topic, Bufeta - Càncer - Tractament, medicine.medical_specialty, Clinical Guides in Oncology, Cystectomy, 03 medical and health sciences, Immune checkpoint inhibitors, Metàstasi, Atezolizumab, Internal medicine, medicine, Humans, Chemotherapy, Neoplasm Invasiveness, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Urinary Bladder Neoplasms [DISEASES], neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias de la vejiga [ENFERMEDADES], business.industry, Other subheadings::/therapy [Other subheadings], medicine.disease, Regimen, 030104 developmental biology, chemistry, Urinary Bladder Neoplasms, neoplasias::procesos neoplásicos::metástasis neoplásica [ENFERMEDADES], business
وصف الملف: application/pdf
-
10
المؤلفون: Oriol Arpí, Silvia Menendez, Joaquim Bellmunt, Alejo Rodriguez-Vida, Luis Soria-Jiménez, Federico Rojo, Natalia Iarchouk, Nuria Juanpere-Rodero, Joan Albanell, Rachael L. Brake, Anna Hernández-Prat, Alejandro Martínez, Ana Rovira
مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Paclitaxel, Angiogenesis, Cell Survival, Pyridines, medicine.medical_treatment, Morpholines, Administration, Oral, Mechanistic Target of Rapamycin Complex 2, Mechanistic Target of Rapamycin Complex 1, Targeted therapy, 03 medical and health sciences, chemistry.chemical_compound, Mice, 0302 clinical medicine, In vivo, Cell Line, Tumor, Antineoplastic Combined Chemotherapy Protocols, medicine, Animals, Humans, Bufeta--Càncer--Tractament, Molecular Biology, PI3K/AKT/mTOR pathway, Cell Proliferation, Chemotherapy, Benzoxazoles, Bladder cancer, Dose-Response Relationship, Drug, business.industry, Imidazoles, Drug Synergism, medicine.disease, Xenograft Model Antitumor Assays, 030104 developmental biology, Pyrimidines, Oncology, chemistry, Urinary Bladder Neoplasms, 030220 oncology & carcinogenesis, Cancer research, business, Ex vivo
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8edc3951313efc22425bed86488d40ea
http://hdl.handle.net/10230/43764
Find this article in full text from Springer Verlag. 
Full Text via ClinicalKey